In the US, it was allowed in some cases to treat COVID-19 with a “Trump cocktail”

The US food and drug administration (FDA) has authorized the use in emergency cases of a drug made from antibodies treated for President Donald Trump’s COVID-19.

The biotechnology company Regeneron Pharmaceuticals developed REGN-COV2 serum based on monoclonal antibodies basiliximab and imdevimab. Now it is allowed to be used to treat COVID-19 in mild to moderate severity in adults and children from 12 years old. This category also includes patients over 65 years of age and those suffering from chronic diseases.

However, the drug should not be prescribed to patients hospitalized with COVID-19 or in need of oxygen therapy.

The fact that Trump was infected with the coronavirus became known in early October. About a week later, he announced that he was cured and later promised to seek early approval for drugs that had proven positive for him: antibody serums from Regeneron Pharmaceuticals and a drug developed by Eli Lilly and Co.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Author: Steve Cowan
Graduated From Princeton University. He has been at the Free Press since October 2014. Previously worked as a regional entertainment editor.
Function: Chief-Editor

Spelling error report

The following text will be sent to our editors:

132 number 0.266454 time